Opinion

Fears group could just be an echo chamber

Loose financial conditions needed

Time spent pre-IPO can pay off

Gov must address regulatory weakness

Many questions still remain

Board activity has increased during pandemic

Can bitcoin become money?

The accelerated approval of the first new Alzheimer's treatment in almost two decades looks set to drive a new wave of biotech innovation and investment.

Interest in the asset class is clear